HOME >> BIOLOGY >> NEWS
Work with cancer-related proteins garners National Foundation for Cancer Research grant

potential to prevent cancer. Vanderbilt-Ingram scientists have uncovered evidence in the laboratory that suggests COX-2 inhibitors might be helpful in treating cancer as well. These drugs are based on minute differences in physical structure that permit fairly specific targeting of COX-2.

Marnett and his colleagues have recently discovered that endocannabinoid, 2-arachidonyl-glycerol (2-AG), is a substrate for COX-2 and is converted into a series of novel glyceryl-prostaglandins. COX-2 oxygenates natural derivatives of arachidonic acid such as esters and amides whereas COX-1 does not. "There is little difference between COX-1 and COX-2 at the protein level," Marnett said. "But for some reason, COX-1 is always present, while COX-2 only comes on when needed. It comes on like gangbusters, then goes away. Over the past year, we have identified a functional biochemical difference between the two proteins. If we can better understand that difference, we're hopeful that knowledge will allow us to exploit the difference to develop even more specific and effective drugs to prevent and potentially treat cancer."

"With NFCR's funding support, Dr. Marnett will be able to do bold and blue-sky exploration," said Dr. Sujuan Ba, Science Director of the National Foundation for Cancer Research. "We believe the findings from Dr. Marnett's research will aid in the development of the next generation of cancer preventive or therapeutic agents by identifying new molecular targets for drug development."

The National Foundation for Cancer Research is a cancer-related charity fully dedicated to advancing basic science cancer research in the laboratory. Formed in 1973 to support research related to the prevention, treatment and cure of cancer, NFCR encourages and facilitates collaboration and the sharing of ideas and results among scientists so that advances in one field contribute to discoveries in others. The NFCR has provided more than $170 million to fund research that h
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
25-Oct-2000


Page: 1 2 3

Related biology news :

1. Scientists identify molecular structure of cancer-related proteins
2. New molecular link key to cellular proteins involved in cancer progression, other diseases
3. New dye directly reveals activated proteins in living cells
4. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
5. Scientists discover proteins involved in spread of HIV-1 infection
6. New mechanism for display of foreign proteins to immune system
7. Scientists visualise cellular handmaiden that restores shape to proteins
8. Hopkins scientists use blood proteins to detect ovarian cancer
9. Viral proteins may prevent bacterial infections
10. Misfiring proteins tied to inflammation and sick feeling of type 2 diabetics
11. Good bacteria trigger proteins to protect the gut

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/23/2017)... 2017  Hunova, the first robotic gym for the rehabilitation and functional ... in Genoa, Italy . The first 30 robots will ... USA . The technology was developed and patented at ... IIT spin-off Movendo Technology thanks to a 10 million euro investment from ... click: ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the ... won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to ... Experience from US2020. , US2020’s mission is to change the trajectory of STEM ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology:
Cached News: